STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY19); Net Profit Down 72.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 21st October 2019, due to Assembly Elections in Maharashtra.

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY19); Net Profit Down 72.2%
Tue, 6 Nov

STRIDES PHARMA SCIENCE has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

STRIDES PHARMA SCIENCE Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m9,9566,6357,32610.4%-26.4%
Other incomeRs m22310677-27.3%-65.3%
TurnoverRs m10,1796,7417,4049.8%-27.3%
ExpensesRs m8,6445,8276,3308.6%-26.8%
Gross profitRs m1,17375892221.6%-21.4%
DepreciationRs m5434294453.8%-18.1%
InterestRs m6194414859.9%-21.7%
Profit before taxRs m234-570-70.2%
TaxRs m42-4316-61.3%
Profit after taxRs m193385442.6%-72.2%
Gross profit margin%11.811.412.6
Effective tax rate%17.8837.323.1
Net profit margin%1.90.60.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 26.4% on a year-on-year (YoY) basis. The expenses were down by 26.8% YoY during the same period.
  • The company's operating profit declined by 21.4% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 12.6% in 2QFY19 as against 11.8% in 2QFY18.
  • Depreciation charges declined by 18.1% and finance costs declined by 21.7% YoY, respectively.
  • Other income declined by 65.3% YoY during the quarter.
  • Net profit for the quarter declined by 72.2% YoY. Net profit margins during the quarter declined from 1.9% in 2QFY18 to 0.7% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 10.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 8.6% QoQ during the same period.
  • The company's operating profit increased by 21.6% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 12.6% in 2QFY19 as against 11.4% in 1QFY18.
  • Net profit for the quarter increased by 42.6% QoQ, while net profit margins increased from 0.6% in 1QFY18 to 0.7% in 2QFY19.

To see how STRIDES PHARMA SCIENCE has performed over the last eight quarters, please visit here.

STRIDES PHARMA SCIENCE Share Price Performance

Over the last one year, STRIDES PHARMA SCIENCE share price has moved up from Rs 821.0 to Rs 429.8, registering a Loss of Rs 391.3 or around 47.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,469.3 (down 0.0%). Over the last one year it has moved down from 14,548.5 to 14,469.3, a gain of 79 points (down 0.5%).

Overall, the S&P BSE SENSEX is up 4.1% over the year.

Current Valuations

At the current price of Rs 429.8, the price to earnings (P/E) ratio of STRIDES PHARMA SCIENCE stands at 48.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.0 times.

Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY19); Net Profit Down 72.2%". Click here!

  

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Oct 18, 2019 (Close)

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE 5-YR ANALYSIS

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS